Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

  • Birgit S. Geurts
  • , Thomas W. Battaglia
  • , J. Maxime van Berge Henegouwen
  • , Laurien J. Zeverijn
  • , Gijs F. de Wit
  • , Louisa R. Hoes
  • , Hanneke van der Wijngaart
  • , Vincent van der Noort
  • , Paul Roepman
  • , Wendy W.J. de Leng
  • , Anne M.L. Jansen
  • , Frans L. Opdam
  • , Maja J.A. de Jonge
  • , Geert A. Cirkel
  • , Mariette Labots
  • , Ann Hoeben
  • , Emile D. Kerver
  • , Adriaan D. Bins
  • , Frans G.L. Erdkamp
  • , Johan M. van Rooijen
    • Danny Houtsma, Mathijs P. Hendriks, Jan Willem B. de Groot, Henk M.W. Verheul, Hans Gelderblom, Emile E. Voest*
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)
37 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology